Clinical Trial 46528

Brooklyn, NY 11235


Summary:

A Phase 3, Multicenter, Randomized, Efficacy Assessor-Blinded Study of Risankizumab
Compared to Ustekinumab for the Treatment of Adult Subjects With Moderate to Severe Crohn's
Disease Who Have Failed Anti-TNF therapy



You may qualify to participate if you meet the following requirements:
• 18 to 80 years of age
• Diagnosed with Crohn’s disease for at least 3 months
• Currently have Crohn’s disease symptoms
• Have found that at least one Crohn’s medication, referred to as a biologic agent, doesn’t work well for you.


Qualified Participants May Receive:

Screening (V1): $150
Baseline (V2): $150
Week 4 (V3): $150
Week 8 (V4): $150
Week 12 (V5): $150
Week 16 (V6): $150
Week 20 (V7): $150
Week 24 (V8): $150
Week 28 (V9): $150
Week 32 (V10): $150
Week 36 (V11): $150
Week 40 (V12): $150
Week 44 (V13): $150
Week 48 (V14): $150
140 Day Follow up (Visit 15): $150
Unscheduled Visit: $150
Colonoscopy Procedure each occurrence: $250


Available At:

Triboro GI / NY Scientific Research Center
1672 Sheepshead Bay
Brooklyn, NY 11235
View Clinic Location

 


If you or someone you care for is interested in participating and lives within 25 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.